Zyvox

Zyvox

linezolid

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Linezolid
Indications/Uses
Nosocomial & community-acquired pneumonia including concurrent bacteremia; complicated & uncomplicated skin & skin structure infections; vancomycin-resistant Enterococcus faecium infections including concurrent bacteremia.
Dosage/Direction for Use
Adult & adolescent ≥12 yr Nosocomial & community-acquired pneumonia, complicated skin & skin structure infections 600 mg IV or PO every 12 hr for 10-14 days. Vancomycin-resistant Enterococcus faecium infections 600 mg IV or PO every 12 hr for 14-28 days. Uncomplicated skin & skin structure infections Adult 400 mg PO every 12 hr for 10-14 days. Adolescent 600 mg PO every 12 hr for 10-14 days. Childn birth through 11 yr Nosocomial & community-acquired pneumonia, complicated skin & skin structure infections 10 mg/kg IV or PO every 8 hr for 10-14 days. Vancomycin-resistant Enterococcus faecium infections 10 mg/kg IV or PO every 8 hr for 14-28 days. Uncomplicated skin & skin structure infections Childn 5-11 yr 10 mg/kg PO every 12 hr for 10-14 days, <5 yr 10 mg/kg PO every 8 hr for 10-14 days. Premature neonate <7 days 10 mg/kg every 12 hr.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Uncontrolled HTN, pheochromocytoma, thyrotoxicosis, carcinoid syndrome. Concomitant use w/ directly & indirectly acting sympathomimetic, vasopressive & dopaminergic agents, serotonin reuptake inhibitors, TCAs, serotonin 5-HT1 receptor agonists, meperidine or buspirone. Not to be used concomitantly w/in 2 wk of MAOIs.
Special Precautions
Not to be used in patients w/ catheter-related bloodstream infection. Pseudomembraneous colitis; Clostridium difficile-associated diarrhea; lactic acidosis; convulsions, serotonin syndrome. Monitor complete blood count in patients at increased bleeding risk, preexisting myelosuppression; visual function in patients on long-term therapy & w/ new visual symptoms. Concomitant use w/ serotonergic agents eg, antidepressants (SSRIs). Hepatic & severe renal insufficiency. Pregnancy & lactation.
Adverse Reactions
Moniliasis; pancytopenia, leucopenia, thrombocytopenia, reversible & sideroblastic anaemia; anaphylaxis; lactic acidosis; convulsions, peripheral neuropathy, headache, taste alteration; optic neuropathy; vomiting, diarrhoea, nausea, abdominal pain, cramps & distension, tongue & superficial tooth discoloration; bullous skin disorders eg, severe cutaneous AR (eg, toxic epidermal necrolysis, Stevens-Johnson syndrome), angioedema, rash; abnormal haematology & liver function tests.
Drug Interactions
Adrenergic & serotonergic agents. Decreased Cmax & AUC w/ rifampicin.
MIMS Class
ATC Classification
J01XX08 - linezolid ; Belongs to the class of other antibacterials. Used in the systemic treatment of infections.
Presentation/Packing
Form
Zyvox infusion 2 mg/mL
Packing/Price
300 mL x 1's
Form
Zyvox granules for oral susp 20 mg/mL
Packing/Price
150 mL x 1's
Form
Zyvox FC tab 600 mg
Packing/Price
10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in